Abstract
BackgroundLung disease represents the leading cause of mortality and morbidity in patients with systemic sclerosis (SSc). In patients with rapid progressive disease immunoreset by high-dose chemotherapy accompanied by autologous stem...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
